Episodes
Dr. Christy Lane
On this week’s show we talk with Dr. Christy Lane a professor and Chair of the Department of Health and Physical Education at Mount Royal University and a founding member of the Stanford Wearable Health Lab. A key to the future of clinical research is the collection of data outside of medical facilities using sensors and wearables. Before devices from heart rate monitors to sleep monitors can be fully leveraged they need to be validated for clinically meaningful outcomes. Our guest today is working to drive the adoption of sensors and wearables across the healthcare spectrum through academic research and entrepreneurial efforts to drive data driven adoption.
Julio Martinez-Clark
Noah and John talk with Julio Martinez-Clark, the founder and CEO of a Medtech-focused CRO in Latin America. We discuss the history of the region, how much it has changed, and why diversity, talent, government backing, and supportive regulations are making LATAM, and specifically Colombia, an incredible location to run clinical trials.
Brent Wright
Noah and John talk with Brent Wright, a certified orthotist and prosthetist. We diverge from the norm to explore an allied health profession that uses data, innovation, clinical engagement, and participant feedback to create iterative precision designs. We explore the ways technology is reshaping the orthotics industry and where clinical researchers can partner.
Dr. Jayne Morgan
Noah and John talk with Dr. Jayne Morgan, the Executive Director of the COVID Task Force at Piedmont Health, a major healthcare system. We discuss the barriers and opportunities for diversity and inclusion in clinical trials.
Ken Getz
Noah and John talk with Ken Getz, the Executive Director of Tufts Center for the Research of Drug Development. We discuss timing in entrepreneurship, following the data, and how industry and academia can successfully collaborate to advance clinical research operations.
Randy Sears
Noah and John talk with Randy Sears, the Program Operations Director of the Masters or Management in Clinical Informatics at Duke University. Prior to leading in education Randy had a long career in telecommunications. We discuss career pivots, navigating changes, and the rise and fall of organizations.
Kendal Whitlock
Noah and John talk with Kendal Whitlock, a leader in innovation and organizational change with a successful career in the pharmaceutical industry. We discuss what it takes to drive innovation within large companies and the interconnection between inclusion and decentralized clinical trials (DCTs).
Dan Agroskin
Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.
Michael Binks
Noah and John talk with Dr. Michael Binks, a VP of Rare Disease Clinical Research at a major pharmaceutical company and a leader in rare disease drug development. We explore the journey from bedside to bench, and back, the unique barriers to drug development in rare disease, and how emerging technologies may shape clinical development in the future.
Sally Okun
Noah and John talk with Stacy Newalu, a former FDA regulator who has built a career in compliance and quality control. We discuss auditing, creating compliant companies, and how companies pushing the boundaries of innovation can help regulators interpret guidance in new contexts.
Stacy Newalu
Noah and John talk with Stacy Newalu, a former FDA regulator who has built a career in compliance and quality control. We discuss auditing, creating compliant companies, and how companies pushing the boundaries of innovation can help regulators interpret guidance in new contexts.
Esther Howard
Noah and John talk with Esther Howard, an expert on oncology trials. We discuss limitations and opportunities for effective decentralized data collection in cancer studies as well as what flexibility can mean for patient mental health.
Tina Barton
On this episode, Noah and John talk with Tina Barton, a dedicated clinical researcher, about emerging markets, what Africa means for the future of clinical research, and why clinical research and should expand across the region.
Tom Grundstrom
Noah and John talk with Tom Grundstrom, a veteran of the clinical research industry, about the supply chain demands within clinical research and how those have shifted with new medication, decentralization, and home health applications.
James Riddle
On this episode, Noah and John talk with James Riddle, a global advisor on human subject protection, biosafety, and ethical practices in clinical research about the challenges global ethical bodies face and how innovative companies can evolve their approach to speed approvals and ensure participant safety.
Brigham Hyde
Noah and John talk with Dr. Brigham Hyde, a healthcare data focused entrepreneur, about the rise of Real World Data (RWD) and Real World Evidence (RWE) and the practical implications of these trends on the clinical research industry.
Christine
Von Raesfeld
On this episode, Noah and John talk with Christine Von Raesfeld, a patient advocate and voice in the world of clinical trials, about the role of participants, why their experience matters, and why the future of data rights will impact studies.
Rohit Nambisan
Noah and John talk with Rohit Nambisan, a leader in AI and Machine learning about what these technologies mean for the evolution of clinical research.
Sinéad Callinan
On this episode, Noah and John talk with Sinéad Callinan, a leader in operationalizing clinical research in Europe about what GDPR and the regulatory framework mean for decentralized clinical trial approaches.
Moe Alsumidaie
On this episode, Noah and John talk with Sinéad Callinan, a leader in operationalizing clinical research in Europe about what GDPR and the regulatory framework mean for decentralized clinical trial approaches.
Dr. Amir Kalali
Noah and John talk with Dr. Amir Kalali, an industry veteran who has driven collaborative efforts throughout his career including CNS Summit and DTRA.
Matt Walz
On this episode, Noah and John talk with Matt Walz, the CEO of a digital recruitment company working to bring the right patients in the right studies on time
Craig Lipset
Noah and John talk with Craig Lipset, a thought leader on implementing digital technology in clinical trials about the history and future of decentralized trials.
Brad Hightower
On this episode, John and Noah sit down with Brad Hightower, the CEO of a site network to discuss the critical role of sites in clinical research and how that role is evolving.